Search
for
Sort by
Research 241–270 of 1000+
- News in brief
- Hair Sciences: An interview with Dr. Rodney Sinclair on female pattern hair loss
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
- Importance of microRNAs in skin morphogenesis and diseases.
- MicroRNA/mRNA regulatory networks in the control of skin development and regeneration
- The biology and clinical application of systemic glucocorticoids
- Clinical Impact of Molecular Diagnostics in Endocrinology
- New insights into microRNA in dermatological diseases
- 555 Dermal single-cell atlas: a novel tool to explore fibroblast heterogeneity
- Molecular Mechanisms Regulating Hair Follicle Development
- Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
- Skin tissue engineering
- Regenerative Medicine of Epidermal Structures
- The Circadian Clock in Skin
- Role of FGFR2-signaling in the pathogenesis of acne
- Preparation of hair beads and hair follicle germs for regenerative medicine
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Netherton Syndrome Associated with Growth Hormone Deficiency
- HYPOPIGMENTED MYCOSIS FUNGOIDES IN A CHILD SUCCESSFULLY TREATED WITH UVA1-LIGHT
- UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- Exploring the Differentiation Abilities of Hair Follicle and Dental Pulp Stem Cells Into Islet Like Cells
- Diseases of the Canine Prostate Gland
- Sebaceous gland diseases: clinical picture risk factors and treatment
- Hairy Math: Addition of Wnt-3a to Multiply Bulge Cells
- Contents Vol. 231, 2015
- Ectodysplasin research—Where to next?
- TERMIS ‐ AMERICAS Toronto, Ontario, Canada July 10–13, 2022
- Effects of Guasha on histomorphology of scraped skins and on expression of calcitonin gene-related peptide and substance P in rats
- Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase-I Study
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets